develop
cpg
oligodeoxynucleotid
cpg
odn
base
therapi
prevent
treatment
sever
acut
respiratori
syndrom
sar
select
novel
cpg
odn
display
btype
cpg
odn
structur
featur
atyp
cpg
odn
structur
featur
test
antisarscov
activ
found
supernat
human
pbmc
stimul
significantli
protect
vero
cell
sarscov
infect
could
stimul
human
pbmc
pdc
secret
high
level
ifna
promot
human
pbmc
b
cell
prolifer
furthermor
demonstr
could
activ
b
cell
nk
cell
human
pbmc
addit
could
enhanc
nk
cytotox
ifng
secret
human
pbmc
togeth
repres
novel
type
cpg
odn
may
potenti
develop
treatment
prevent
sar
well
viral
associ
diseas
immunostimulatori
activ
cpg
oligodeoxynucleotid
cpg
odn
extens
studi
recent
year
base
function
characterist
cpg
odn
divid
three
type
atyp
cpg
odn
capabl
activ
human
plasmacytoid
dendrit
cell
pdc
produc
larg
amount
type
interferon
ifna
h
strongli
activ
natur
killer
cell
nk
cell
btype
cpg
odn
primarili
activ
b
cell
result
prolifer
antibodi
secret
ctype
cpg
odn
share
activ
aand
btype
cpg
odn
cpg
odn
wide
test
prevent
treat
viral
infect
hiv
replic
human
fetal
thymocyt
strongli
inhibit
cpg
odn
subcutan
inject
cpg
odn
sheep
induc
dosedepend
increas
synthetas
antivir
effector
molecul
serum
sheep
administr
cpg
odn
genit
tract
enhanc
innat
immun
protect
mice
herp
viru
infect
mice
pretreat
cpg
odn
respiratori
syncyti
viru
rsv
infect
produc
larg
amount
ifng
lung
associ
significantli
reduc
mucu
secret
viru
treatment
friend
virusinfect
mice
cpg
odn
significantli
reduc
viru
burden
blood
enhanc
virusspecif
cellular
immun
respons
administr
cpg
odn
mice
senescenceacceler
model
mice
induc
quick
clearanc
influenza
viru
consider
improv
surviv
mice
challeng
lethal
dose
influenza
viru
recent
treatment
hepat
c
patient
cpg
odn
report
reduc
hepat
c
viru
hcv
rna
phase
studi
reduct
consist
elev
ifna
marker
associ
antivir
immun
respons
late
sever
acut
respiratori
syndrom
sar
mysteri
develop
guangdong
provinc
peopl
republ
china
spread
countri
infect
character
fever
dri
nonproduct
cough
short
breath
death
progress
respiratori
failur
occur
case
novel
coronaviru
sarscov
isol
sar
patient
identifi
etiolog
link
outbreak
sar
spread
sever
sar
churn
surg
develop
vaccin
drug
control
treatment
sar
laboratori
develop
test
larg
number
cpg
odn
order
develop
cpg
odn
base
therapi
prevent
treatment
sar
first
system
screen
function
cpg
odn
stimul
human
peripher
blood
mononuclear
cell
pbmc
produc
antivir
activ
analyz
antivir
bioassay
select
novel
type
cpg
odn
show
potent
abil
antivsv
activ
bioassay
display
btype
cpg
odn
structur
featur
atyp
cpg
odn
structur
featur
show
potent
activ
inhibit
cytolyt
effect
sarscov
vero
cell
found
display
function
activ
ctype
cpg
odn
induc
human
pbmc
plasmacytoid
dendrit
cell
pdc
produc
high
level
ifna
stimul
human
pbmc
b
cell
prolifer
activ
b
cell
nk
cell
suggest
novel
type
cpg
odn
may
potenti
develop
antisar
prevent
therapi
nucleaseresist
phosphorothioatemodifi
odn
synthes
sangon
biotech
compani
shanghai
china
cpg
odn
use
studi
tcg
ggt
gcg
acg
tcg
cag
ggg
gga
cga
tcg
tcg
ggg
tcg
ttt
tgt
cgt
tttg
tcg
tgg
ggt
ggc
agc
tgc
cag
ggg
except
cg
sequenc
revers
lowercas
capit
letter
repres
phosphorothio
phosphodiest
linkag
respect
odn
dilut
te
buffer
mm
tri
mm
edta
ph
test
endotoxin
use
limulu
amebocyt
lysat
assay
associ
cape
cod
inc
reagent
use
pyrogenfre
reagent
human
pbmc
isol
buffi
coat
blood
center
jilin
provinc
china
ficol
hypaqu
densiti
gradient
centrifug
pharmacia
viabil
pbmc
determin
trypan
blue
exclus
plasmacytoid
dendrit
cell
pdc
purifi
human
pbmc
deplet
lymphocyt
monocyt
neutrophil
granulocyt
dilut
antibodi
dilut
antimous
igg
magnet
bead
dynal
antibodi
neg
cell
sort
lin
pdc
cell
posit
select
use
magnet
bead
dynal
briefli
quantiti
bead
ad
pbmc
gentli
mix
bidirect
specimen
mixer
min
b
cell
isol
place
tube
magnet
particl
concentr
min
supernat
remov
pipet
remain
cell
wash
three
time
iscov
modifi
dulbecco
medium
imdm
gibco
vero
cell
african
green
monkey
kidney
cell
line
american
type
cultur
collect
cultur
co
humidifi
incub
maintain
imdm
supplement
vv
heatinactiv
fetal
bovin
serum
fb
gibco
antibiot
iu
penicillinml
iu
streptomycinml
vesicular
stomat
viru
vsv
grown
vero
cell
titrat
viru
store
aliquot
use
sarscov
strain
use
isol
sar
patient
youanmen
hospit
beij
identifi
rtpcr
viru
neutral
test
dna
sequenc
viru
propag
vero
cell
titrat
cytopath
effect
cpe
method
experi
involv
sarscov
carri
level
laboratori
chines
diseas
control
center
beij
complianc
guidelin
govern
regul
antivir
activ
cultur
supernat
cpg
odntreat
human
pbmc
measur
describ
briefli
supernat
pbmc
ml
stimul
without
cpg
odn
h
collect
store
aliquot
use
vero
cell
well
seed
flatbottom
plate
cultur
h
confluenc
cell
incub
al
dilut
supernat
h
challeng
tissu
cultur
infecti
dose
vsv
sarscov
anoth
h
stain
crystal
violet
cytopath
effect
viru
examin
use
multiwel
microtit
plate
reader
nm
express
od
valu
human
pbmc
ml
human
pdc
well
al
medium
treat
differ
cpg
odn
agml
h
supernat
harvest
determin
cytokin
elisa
kit
ifna
pierc
ifng
r
system
use
detect
ifna
ifng
supernat
accord
manufactur
protocol
cytokin
level
supernat
quantit
calcul
base
standard
curv
prolifer
human
pbmc
human
b
cell
determin
h
thymidin
incorpor
assay
describ
previous
briefli
pbmc
well
b
cell
well
plate
ubottom
plate
costar
cultur
without
cpg
odn
agml
h
follow
puls
h
thymidin
new
england
nuclear
boston
h
cell
harvest
glass
fiber
filter
detect
scintil
counter
cell
prolifer
express
mean
cpm
count
per
minut
triplet
well
sd
pbmc
incub
without
cpg
odn
ag
ml
h
wash
twice
fac
stain
buffer
pb
supplement
bsa
nan
mm
edta
analyz
express
variou
cell
surfac
molecul
dualcolor
stain
fitclabel
mab
bd
bioscienc
pelabel
mab
bd
bioscienc
follow
analysi
facscalibur
nk
cytotox
human
pbmc
stimul
cpg
odn
assay
use
cell
target
cell
briefli
human
pbmc
incub
cpg
odn
agml
h
harvest
effector
cell
cell
label
cr
h
use
target
cell
stimul
pbmc
variou
number
seed
ubottom
plate
incub
crlabel
cell
well
final
volum
al
h
end
incub
al
supernat
harvest
well
count
gcounter
cr
releas
spontan
maxim
releas
determin
presenc
either
medium
triton
respect
result
express
mean
percentag
specif
lysi
triplet
well
sd
specif
lysi
experiment
count
mean
spontan
releas
count
mean
maxim
releas
count
mean
spontan
releas
count
data
shown
mean
sd
statist
signific
differ
determin
pair
twotail
student
test
differ
consid
statist
signific
p
less
identifi
cpg
odn
immunestimul
activ
synthes
seri
cpg
odn
test
abil
stimul
human
pbmc
produc
factor
could
protect
vero
cell
vsv
infect
one
cpg
odn
design
stood
possess
antivir
activ
studi
detail
two
wellknown
prototyp
cpg
odn
atyp
cpg
odn
btype
cpg
odn
use
control
vsv
protect
assay
human
pbmc
stimul
control
cpg
odn
cultur
supernat
test
abil
protect
vero
cell
vsv
infect
shown
fig
supernat
protect
vero
cell
challeng
vsv
level
protect
similar
induc
p
significantli
higher
induc
p
antivir
activ
due
presenc
cg
dinucleotid
share
sequenc
except
order
cg
revers
induc
antivsv
activ
supernat
cultur
human
pbmc
determin
kinet
antivir
activ
induc
stimul
human
pbmc
agml
differ
time
stimul
min
h
supernat
assay
antivir
activ
although
h
follow
stimul
antivir
activ
yet
appar
supernat
quit
high
h
follow
stimul
fig
activ
reach
peak
level
h
maintain
peak
level
h
antivir
activ
exhibit
similar
kinet
induc
observ
antivir
activ
result
show
antivir
activ
induc
appear
within
hour
maintain
least
day
base
featur
kinet
test
dose
stimul
antivir
activ
human
pbmc
treat
differ
amount
h
supernat
use
measur
antivir
activ
vsv
protect
assay
signific
antivsv
activ
detect
agml
use
fig
activ
increas
sharpli
agml
use
reach
plateau
level
agml
use
antivsv
activ
induc
show
similar
profil
except
activ
decreas
high
cpg
odn
concentr
ag
ml
result
indic
potent
suffici
induc
signific
antivir
activ
low
concentr
seek
antisarscov
cpg
odn
test
abil
induc
antisarscov
activ
human
pbmc
stimul
agml
cultur
supernat
test
abil
protect
vero
cell
infect
sarscov
strain
shown
fig
supernat
significantli
protect
vero
cell
sarscov
infect
even
supernat
dilut
estim
rel
level
antisarscov
activ
induc
measur
ifna
supernat
elisa
found
could
stimul
human
pbmc
produc
high
level
ifna
could
fig
result
show
could
protect
vero
cell
sarscov
infect
dosedepend
manner
higher
dose
uml
display
stronger
antisarscov
activ
fig
lower
dose
uml
lost
antisarscov
activ
result
demonstr
ifna
supernat
human
pbmc
stimul
major
antisarscov
factor
display
function
featur
ctype
cpg
odn
cpg
odn
shown
induc
human
pdc
produc
type
interferon
includ
ifnah
import
antivir
factor
measur
ifna
secret
human
pbmc
purifi
pdc
follow
stimul
result
show
could
stimul
human
pbmc
secret
ifna
averag
ifna
level
supernat
pgml
lower
induc
fig
left
sinc
pdc
major
cell
ifna
product
purifi
pdc
human
pbmc
stimul
differ
cpg
odn
agml
h
supernat
detect
ifna
product
result
show
could
stimul
human
pdc
produc
high
level
ifna
pgml
approxim
half
pgml
induc
fig
right
result
demonstr
display
function
featur
atyp
cpg
odn
next
measur
abil
stimul
b
cell
prolifer
human
pbmc
purifi
b
cell
show
prolifer
human
pbmc
stimul
obvious
higher
stimul
lower
stimul
fig
left
furthermor
purifi
b
cell
use
prolifer
assay
result
show
could
also
stimul
b
cell
prolifer
prolifer
level
b
cell
activ
lower
signific
higher
fig
right
result
reveal
also
display
function
featur
btype
cpg
odn
display
btype
cpg
odn
structur
featur
atyp
cpg
odn
structur
featur
see
materi
method
structur
featur
might
reason
function
induc
antivir
activ
stimul
prolifer
b
cell
togeth
result
show
novel
ctype
cpg
odn
share
function
featur
atyp
cpg
odn
btype
cpg
odn
identifi
type
cell
activ
human
pbmc
cultur
cpg
odn
agml
h
stain
pelabel
mab
fitclabel
mab
analyz
flowcytometri
could
upregul
express
cell
b
cell
cell
nk
cell
potenc
activ
b
cell
stronger
activ
nk
cell
similar
contrast
cell
monocyt
could
activ
cpg
odn
fig
could
activ
immun
cell
pbmc
result
demonstr
activ
b
cell
nk
cell
human
pbmc
test
whether
could
promot
nk
cell
kill
activ
crlabel
cell
use
target
cell
result
reveal
nk
kill
activ
pbmc
stronger
pbmc
weaker
pbmc
fig
result
show
nk
cell
human
pbmc
display
enhanc
cytotox
ifng
assay
demonstr
could
stimul
human
pbmc
produc
signific
amount
ifng
contrast
could
fig
result
suggest
nk
cell
activ
may
secret
ifng
studi
report
novel
type
cpg
odn
strong
activ
cytolyt
activ
sarscov
antisarccov
activ
correl
abil
induc
human
pbmc
produc
ifna
dosedepend
fashion
late
spread
sever
sar
prompt
search
develop
antisarscov
compound
recombin
ifnh
shown
exhibit
highest
antivir
activ
sarscov
vitro
pegyl
ifna
shown
reduc
viral
replic
excret
sarscov
infect
macaqu
find
suggest
possibl
applic
type
ifn
treat
sar
patient
howev
direct
applic
type
ifn
sever
drawback
first
repeat
applic
recombin
ifna
human
induc
antibodi
respons
result
loss
therapeut
efficaci
second
least
subtyp
ifna
human
difficult
produc
human
use
fact
natur
ifna
found
higher
antivir
activ
sarscov
vitro
recombin
ifna
probabl
due
presenc
multipl
subtyp
ifna
follow
natur
induct
overcom
difficult
one
possibl
use
cpg
odn
induc
product
ifn
endogen
cell
show
induc
human
pbmc
pdc
secret
larg
amount
ifna
inde
least
eight
subtyp
ifna
produc
follow
stimul
human
pbmc
data
shown
consist
pbmc
supernat
exhibit
potent
antisarscov
activ
innat
immun
system
nk
cell
first
line
defens
viral
infect
cell
contribut
resist
earli
phase
viral
infect
addit
activ
nk
cell
monocyt
also
produc
cytokin
may
exhibit
differ
antiviru
activ
found
nk
cell
human
pbmc
could
activ
activ
cell
probabl
indirect
studi
shown
cpg
odninduc
type
ifn
cytokin
chemokin
trigger
wide
rang
secondari
effect
includ
nk
cell
activ
studi
also
found
could
enhanc
nk
cell
cytotox
stimul
human
pbmc
impli
capabl
trigger
innat
antiviru
immun
vivo
includ
type
ifn
product
nk
activ
previou
studi
reveal
innat
immun
activ
cpg
odn
might
lead
gener
adapt
immun
respons
found
could
activ
b
cell
human
pbmc
might
possibl
indic
prime
humor
branch
specif
immun
system
paper
prototyp
atyp
cpg
odn
use
control
studi
antivir
activ
found
induc
similar
antivsv
activ
human
pbmc
stimul
higher
level
ifna
product
human
pbmc
pdc
data
suggest
also
optim
cpg
odn
induc
antisarscov
immun
compar
light
applic
full
phosphorothio
backbon
may
resist
nucleas
digest
whose
backbon
partial
phosphorothio
furthermor
ctype
cpg
odn
properti
may
make
potenti
medica
stimul
branch
antisarscov
immun
base
data
propos
applic
may
sever
advantag
treat
sar
viral
infect
induc
endogen
mix
ifna
induc
rapid
antiviru
respons
activ
nk
cell
activ
b
cell
collect
data
suggest
may
attract
candid
develop
antivir
drug
treat
sarscov
viru
infect
